Cargando…
Cardiovascular Safety Assessment in Cancer Drug Development
The development of cardiovascular toxicity attributable to anticancer drugs is a pivotal event that is associated with cardiovascular morbidity as well as with worse cancer‐specific and overall outcomes. Although broad consensus exists regarding the importance of cardiovascular safety assessment in...
Autores principales: | Oren, Ohad, Neilan, Tomas G., Fradley, Michael G., Bhatt, Deepak L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075223/ https://www.ncbi.nlm.nih.gov/pubmed/34913360 http://dx.doi.org/10.1161/JAHA.121.024033 |
Ejemplares similares
-
Role of Semaphorin Signaling During Cardiovascular Development
por: Sun, Qianchuang, et al.
Publicado: (2018) -
Contemporary Cardiovascular Imaging Methods for the Assessment of At‐Risk Myocardium
por: Wince, W. Benjamin, et al.
Publicado: (2014) -
Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives
por: De Luca, Leonardo, et al.
Publicado: (2021) -
Treatment, Behavioral, and Psychosocial Components of Cardiovascular Disease Risk Among Survivors of Childhood and Young Adult Cancer
por: Berkman, Amy M., et al.
Publicado: (2015) -
Imaging Cardiovascular Calcification
por: Wang, Ying, et al.
Publicado: (2018)